The Jumonji family: past, present and future of histone demethylases in cancer

The first Jumonji gene was cloned in 1995 by Takeuchi et al. [Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 1995; 9: 1211–22.]. Several genes sharing similar b...

Full description

Bibliographic Details
Main Authors: Franci Gianluigi, Ciotta Alfonso, Altucci Lucia
Format: Article
Language:English
Published: De Gruyter 2014-06-01
Series:Biomolecular Concepts
Subjects:
Online Access:https://doi.org/10.1515/bmc-2014-0010
_version_ 1818677767414218752
author Franci Gianluigi
Ciotta Alfonso
Altucci Lucia
author_facet Franci Gianluigi
Ciotta Alfonso
Altucci Lucia
author_sort Franci Gianluigi
collection DOAJ
description The first Jumonji gene was cloned in 1995 by Takeuchi et al. [Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 1995; 9: 1211–22.]. Several genes sharing similar biological features have since been discovered, and are currently grouped into the JMJ family. Interestingly, their deregulation has been associated with cardiac disease, obesity, neurological disorders and cancer. One of the mechanisms underlying their function is gene expression modulation via histone post-translational modifications (PTMs). Increasing evidence of Jumonji deregulation in tumours such as colon, prostate, haematological and breast cancer is continually emerging, hence the need to acquire a better understanding. The Genesapiens.org database of patient arrays allows target expression levels to be investigated in a wide range of cancers, corroborating and extending the role of the JMJ family. Here, we provide an overview of the expression profile and regulation of JMJ family members in cancer, examining the most recent literature in the light of analyses drawn from this database.
first_indexed 2024-12-17T09:04:36Z
format Article
id doaj.art-ca197e84e3bb4063850dd9707eb58327
institution Directory Open Access Journal
issn 1868-5021
1868-503X
language English
last_indexed 2024-12-17T09:04:36Z
publishDate 2014-06-01
publisher De Gruyter
record_format Article
series Biomolecular Concepts
spelling doaj.art-ca197e84e3bb4063850dd9707eb583272022-12-21T21:55:34ZengDe GruyterBiomolecular Concepts1868-50211868-503X2014-06-015320922410.1515/bmc-2014-0010The Jumonji family: past, present and future of histone demethylases in cancerFranci Gianluigi0Ciotta Alfonso1Altucci LuciaDipartimento di Biochimica, Biofisica e Patologia Generale, Seconda Università degli Studi di Napoli, Vico L. De Crecchio 7, I-80138 Napoli, ItalyDipartimento di Biochimica, Biofisica e Patologia Generale, Seconda Università degli Studi di Napoli, Vico L. De Crecchio 7, I-80138 Napoli, ItalyThe first Jumonji gene was cloned in 1995 by Takeuchi et al. [Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 1995; 9: 1211–22.]. Several genes sharing similar biological features have since been discovered, and are currently grouped into the JMJ family. Interestingly, their deregulation has been associated with cardiac disease, obesity, neurological disorders and cancer. One of the mechanisms underlying their function is gene expression modulation via histone post-translational modifications (PTMs). Increasing evidence of Jumonji deregulation in tumours such as colon, prostate, haematological and breast cancer is continually emerging, hence the need to acquire a better understanding. The Genesapiens.org database of patient arrays allows target expression levels to be investigated in a wide range of cancers, corroborating and extending the role of the JMJ family. Here, we provide an overview of the expression profile and regulation of JMJ family members in cancer, examining the most recent literature in the light of analyses drawn from this database.https://doi.org/10.1515/bmc-2014-0010cancerchromatin-modulating drugsepigeneticshistone demethylasesjumonji family.
spellingShingle Franci Gianluigi
Ciotta Alfonso
Altucci Lucia
The Jumonji family: past, present and future of histone demethylases in cancer
Biomolecular Concepts
cancer
chromatin-modulating drugs
epigenetics
histone demethylases
jumonji family.
title The Jumonji family: past, present and future of histone demethylases in cancer
title_full The Jumonji family: past, present and future of histone demethylases in cancer
title_fullStr The Jumonji family: past, present and future of histone demethylases in cancer
title_full_unstemmed The Jumonji family: past, present and future of histone demethylases in cancer
title_short The Jumonji family: past, present and future of histone demethylases in cancer
title_sort jumonji family past present and future of histone demethylases in cancer
topic cancer
chromatin-modulating drugs
epigenetics
histone demethylases
jumonji family.
url https://doi.org/10.1515/bmc-2014-0010
work_keys_str_mv AT francigianluigi thejumonjifamilypastpresentandfutureofhistonedemethylasesincancer
AT ciottaalfonso thejumonjifamilypastpresentandfutureofhistonedemethylasesincancer
AT altuccilucia thejumonjifamilypastpresentandfutureofhistonedemethylasesincancer
AT francigianluigi jumonjifamilypastpresentandfutureofhistonedemethylasesincancer
AT ciottaalfonso jumonjifamilypastpresentandfutureofhistonedemethylasesincancer
AT altuccilucia jumonjifamilypastpresentandfutureofhistonedemethylasesincancer